ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 103 filers reported holding ADICET BIO INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $529,774 | +108.0% | 386,696 | +269.0% | 0.00% | 0.0% |
| Q2 2023 | $254,654 | -52.1% | 104,796 | +13.5% | 0.00% | 0.0% |
| Q1 2023 | $531,625 | -67.2% | 92,296 | -49.1% | 0.00% | -80.0% |
| Q4 2022 | $1,620,786 | -45.9% | 181,296 | -14.0% | 0.01% | -44.4% |
| Q3 2022 | $2,996,000 | -28.6% | 210,696 | -26.7% | 0.01% | -25.0% |
| Q2 2022 | $4,197,000 | -23.8% | 287,496 | +4.2% | 0.01% | -20.0% |
| Q1 2022 | $5,510,000 | +37.2% | 275,896 | +20.1% | 0.02% | +50.0% |
| Q4 2021 | $4,017,000 | +621.2% | 229,696 | +223.1% | 0.01% | +900.0% |
| Q3 2021 | $557,000 | -50.6% | 71,081 | -35.1% | 0.00% | -66.7% |
| Q2 2021 | $1,128,000 | +12.9% | 109,581 | +43.5% | 0.00% | 0.0% |
| Q1 2021 | $999,000 | +137.3% | 76,381 | +154.8% | 0.00% | +200.0% |
| Q4 2020 | $421,000 | -12.7% | 29,981 | -26.1% | 0.00% | 0.0% |
| Q3 2020 | $482,000 | – | 40,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |